The Leukocyte-Common Antigen (L-CA) Family

  • A. Neil Barclay
  • David I. Jackson
  • Anthony C. Willis
  • Alan F. Williams
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 237)


The leukocyte common antigen (L-CA, T200, Ly-5 or CD45) consists of a family of abundant membrane glycoproteins of apparent Mr 180–240k present on all lymphoid and myeloid cells but absent from other tissues (1–4). The L-CA shows cell type specific heterogeneity in apparent Mr, glucosylation and antigenicity. L-CA from rat thymocytes gives a single major band on SDS PAGE of 180k Mr, whilst T cells give four bands of 180, 190, 200 and 220k Mr and B cells one broad band at 240k (5) and similar patterns are found on mouse and human leukocytes (2,6). Differences in glycosylation in these forms have been shown with anti-carbohydrate antibodies (7) and by lectin binding (8). Antigenic heterogeneity is revealed by antibodies of the higher Mr bands of L-CA seen on SDS PAGE; e.g. the monoclonal antibody. MRC OX-33 is a marker for B cells and the MRC OX-22 monoclonal antibody recognizes B cells, T cytotoxic cells and about 2/3 of T helper cells but not the remainder of the helper cells nor thymocytes (5). The division of T helper cells using this antibody is of particular interest as these sub-populations have important functional differences (9,10). In addition the MRC OX-22 antigenic determinant is stable to trypsin digestion enabling an antigenically active peptide to be purified by antibody affinity chromatography and sequenced (1).


Helper Cell Extra Segment Longe Form Extracellular Part Leukocyte Common Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. W. Fabre and A. F. Williams, Transplantation 23: 349 (1977).PubMedCrossRefGoogle Scholar
  2. 2.
    J. Michaelson, M. Scheid, and E. A. Boyse, Immunogenetics 9: 193 (1979).CrossRefGoogle Scholar
  3. 3.
    R. Dalchau, J. Kirkely and J. W. Fabre, Eur. J. Immunol. 10: 737 (1980).PubMedCrossRefGoogle Scholar
  4. 4.
    I. S. Trowbridge, P. Ralph, and M. J. Bevan, Proc. Natl. Acad. Sci. USA, 72: 157 (1975).PubMedCrossRefGoogle Scholar
  5. 5.
    G. R. Woollett, A. N. Barclay, M. Puklavec, and A. F. Williams, Eur. J. Immunol. 15: 168 (1985).PubMedCrossRefGoogle Scholar
  6. 6.
    I. S. Trowbridge, J. Exp. Med. 148: 313 (1978).PubMedCrossRefGoogle Scholar
  7. 7.
    R. A. Childs, R. Dalchau, P. Scudder, E. F. Hounsell, J. W. Fabre, and T. Feizi, Biochem. Biophys. Res. Comm. 110: 424 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    W. R. A. Brown and A. F. Williams, Immunology 46: 713 (1982).PubMedGoogle Scholar
  9. 9.
    G. P. Spickett, M. R. Brandon, D. W. Mason, A. F. Williams, and G. R. Woollett, J. Exp. Med. 158: 795 (1983).PubMedCrossRefGoogle Scholar
  10. 10.
    R. P. Arthur and D. W. Mason, J. Exp. Med. 163: 774 (1986).PubMedCrossRefGoogle Scholar
  11. 11.
    P. Jonson, A. F. Williams, and G. R. Woollett, in: “Hybridoma Technology in the Biosciences and Medicine” Chapter 9, T. A. Springer, ed., Plenum Press (1985).Google Scholar
  12. 12.
    M. L. Thomas, A. N. Barclay, J. Gagnon, and A. F. Williams, Cell 41: 83 (1985).PubMedCrossRefGoogle Scholar
  13. 13.
    A. N. Barclay, D. I. Jackson, A. C. Willis, and A. F. Williams, EMBO J. 6: 1259 (1987).PubMedGoogle Scholar
  14. 14.
    F.-W. Shen, Y. Saga, G. Litman, G. Freeman, J.-S. Tung, H. Cantor and E. A. Boyse, Proc. Natl. Avad. Sci. USA 82: 7360 (1985).CrossRefGoogle Scholar
  15. 15.
    Y. Saga, J.-S. Tung, F.-W. Shen, and E. A. Boyse, Proc. Natl. Acad. Sci. USA 83: 6940 (1986).PubMedCrossRefGoogle Scholar
  16. 16.
    Y. Saga, J.-S. Tung, F.-W. Shen, and E. A. Boyse, Proc. Natl. Acad. Sci. USA 84: 5364 (1987).PubMedCrossRefGoogle Scholar
  17. 17.
    M. L. Thomas, P. J. Reynolds, A. Chain, Y. Ben-Neriah, and I. S. Trowbridge, Proc. Natl. Acad. Sci. USA 84: 5360 (1987).PubMedCrossRefGoogle Scholar
  18. 18.
    S. J. Ralph, M. L. Thomas, C. C. Morton, and I. S. Trowbridge, EMBO J. 6: 1251 (1987).PubMedGoogle Scholar
  19. 19.
    W. R. A. Brown, A. N. Barclay, C. A. Sunderland, and A. F. Williams, Nature 289: 456 (1981).PubMedCrossRefGoogle Scholar
  20. 20.
    D. A. Shackelford and I. S. Trowbridge, J. Biol. Chem. 261: 8334 (1986).PubMedGoogle Scholar
  21. 21.
    L. Y. W. Bourguignon, S. J. Suchard, M. L. Nagpal, and J. R. Glenny Jr, J. Cell Biol. 101: 477 (1985).PubMedCrossRefGoogle Scholar
  22. 22.
    G. R. Woollett, A. F. Williams, and D. M. Shotton, EMBO J. 4: 2827 (1985).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • A. Neil Barclay
    • 1
  • David I. Jackson
    • 1
  • Anthony C. Willis
    • 2
  • Alan F. Williams
    • 1
  1. 1.MRC Cellular Immunology Unit, Sir William Dunn School of PathologyUniversity of OxfordOxfordEngland
  2. 2.MRC Immunochemistry Department, Department of BiochemistryUniversity of OxfordOxfordEngland

Personalised recommendations